ArticleMolecular therapy. Nucleic acids2025

circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1.

Denisa Baci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.